Drug Information

Drug General Information
Drug ID
D0T1ZO
Drug Name
GDC-0941
Drug Type
Small molecular drug
Indication Breast Cancer [ICD10:C33-C34] Phase 2 [1572603]
Formula
C23H27N7O3S2
PubChem Compound ID
17755052
Drug Resistance Mutation (DRM)
DRM DRM Info
References
Ref 1572603Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.